Hematological Picture of Rabbits Immunized with Pseudomonas aeruginosa
Article Sidebar
Main Article Content
Abstract
The current study was established to find out the role of immunization of Pseudomonas aeruginosa-whole sonicated antigen in adult white fur domestic rabbits. To achieve this goal, fifteen rabbits were allocated into 3 groups, the first group was immunized with P. aeruginosa–whole sonicated antigen and challenged with viable pathogenic P. aeruginosa; the second group (control negative) was treated with phosphate buffer saline and the third group was injected with viable pathogenic P. aeruginosa (control positive). The results demonstrated increasing levels of the measured parameters blood picture (total WBCs, lymphocytes, and granulocytes, RBCs and hemoglobin concentrations) in the first group compared with control negative group (T test was used). In contrast, a sharp fall was noted in total thrombocytes (platelets) count in the first group compared with control negative group. It can be concluded that immunization with P. aeruginosa– whole sonicated antigen may consider as a potent reproducible effective immunogen model for experimental immunological studies in rabbits.
Correspondence: [email protected]
Received: 25 April 2020
Accepted: 26 November 2020
Published: 28 December 2020
Downloads
Article Details
How to Cite
References
Jenny M, Kingsbury J. Properties and prevention: A review of Pseudomonas aeruginosa. J Biol Med Res. 2018; 2: 8.
Defez C, Fabbro-Peray P, Bouziges N, Gouby A, Mahamat A, Daures J, et al. Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection. J Hosp Infect. 2004; 57: 209-216.
Lyczak JB, Cannon CL, Pier GB. Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist. Microb Infect. 2000; 2: 1051-1060.
Ding B, Von Specht B-U, Li Y. OprF/I-vaccinated sera inhibit binding of human interferon-gamma to Pseudomonas aeruginosa. Vaccine. 2010; 28:4119-4122.
Ahmadi H, Tabaraie B, Maleknia S, Pormirzagholi F, Nejati M, Hedayati MH. Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine. J Infect Develop Count. 2012; 6: 721-726.
Priebe GP, Goldberg JB. Vaccines for Pseudomonas aeruginosa: a long and winding road. Exp Rev Vacc. 2014; 13(4):507-519.
Hegerle N, Choi M, Sinclair J, Amin MN, Ollivault-Shiflett M, Curtis B, et al. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. PloS One. 2018; 13(9): e0203143.
Döring G, Dorner F. A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis. Beh Inst Mitt. 1997; 98: 338-344.
Campodónico VL, Llosa NJ, Grout M, Döring G, Maira-Litrán T, Pier GB. Evaluation of flagella and flagellin of Pseudomonas aeruginosa as vaccines. Infect Immun. 2010; 78: 746-755.
Cachia P, Glasier L, Hodgins R, Wong W, Irvin R, Hodges R. The use of synthetic peptides in the design of a consensus sequence vaccine for Pseudomonas aeruginosa. J. Pept. Res. 1998; 52: 289-299.
Thomas LD, Dunkley ML, Moore R, Reynolds S, Bastin DA, Kyd JM, et al. Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung. Vaccine. 2000; 19(2-3): 348-357.
Göcke K, Baumann U, Hagemann H, Gabelsberger J, Hahn H, Freihorst J, et al. Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule. FEMS Immunol Med Microbiol. 2003; 37(2-3): 167-171.
Thomas LD, Kyd JM, Bastin DA, Dunkley ML,Cripps AW. Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa. FEMS Immunol Med Microbiol. 2003; 37(2-3): 155-160.
Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M, Pier GB. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infect Immun. 2003; 71: 3875-3884.
Pier GB. Promises and pitfalls of Pseudomonas aeruginosa lipo-polysaccharide as a vaccine antigen. Carb Res. 2003; 338(13): 2549-2556.
Schaefers MM, Duan B, Mizrahi B, Lu R, Reznor G, Kohane DS, et al. PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen improves Th17 responses and confers protection against experimental acute pneumonia. Vaccine. 2018; 36: 6926-6932.
Islam ST, Taylor VL, Qi M, Lam JS. Membrane topology mapping of the O-antigen flippase (Wzx), polymerase (Wzy), and ligase (WaaL) from Pseudomonas aeruginosa PAO1 reveals novel domain architectures. mBio. 2010; 1(3): e00189-10.
Richard G, Mackenzie CR, Henry KA, Vinogradov E, Hall JC, Hussack G. Antibody binding to the O-specific antigen of Pseudomonas aeruginosa O6 inhibits cell growth. Antimicrob Agents Chemother. 2020 in press.
Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice. Infect Immun. 2011; 79: 3455-3464.
Al-Awadi AQ, Alwan MJ. The influence of whole sonicated Pseudomonas aeruginosa antigens on experimental P. aeruginosa arthritis in rabbits. Iraqi J. Vet. Med. 2014; 38:1-10.
Hobden JA, Engel LS, Callegan MC, Hill JM, Gebhardt BM, O'callaghan RJ. Pseudomonas aeruginosa keratitis in leukopenic rabbits. Current Eye Research. 1993; 12: 461-467.
Gilboa Y, Friedler E. UV disinfection of RBC-treated light greywater effluent: kinetics, survival and regrowth of selected microorganisms. Water Research. 2008; 42: 1043-1050.
Ati AT. Preparation and evaluation of specific Pseudomonas aeruginosa transfer factor to protect the mice against challenge [Thesis]. Baghdad, Iraq: University of Baghdad; 2016.
Henry RJ, Cannon DC, Winkelman JW, editors. Clinical Chemistry, Principal and Techniques. 2nd Edition, England: Harper and Row Company; 1974. p 78.
Jackson JW, Stovall WD. The normal blood count of the rabbit. J Lab Clin Med. 1930; 16(1): 82-87.
Zeng J, Zhang P, Li L, Ren L, Liang P, Huang X. Proteomic study of peripheral blood lymphocytes of rabbits with severe burn and Pseudomonas aeruginosa sepsis. Chin Crit Care Med. 2009; 21: 455-459.
Zhang PH, Yang LR, Li LL, Zeng JZ, Ren LC, Liang PF, et al. Proteomic change of peripheral lymphocytes from scald injury and Pseudomonas aeruginosa sepsis in rabbits. Burns. 2010; 36: 82-88.
Al-Awadi AQ. The influence of Pseudomonas aeruginosa outer membrane antigens on experimental bone infection in rabbits. Int J Sci Nat. 2017; 8(2): 289-297.
Riedel RM, De Matos R, Schaefer DM. Bone marrow cell composition and morphology in healthy juvenile female New Zealand White rabbits (Oryctolagus cuniculus). Am J Vet Res. 2017; 78: 910-918.
Razook BRF, Mahmood MM, Al-ani ANA. Haematological picture of rabbit immunized by Corynebacterium bovis. Plant Arch. 2020; 20(1): 137-140.
Kolpen M, Hansen CR, Bjarnsholt T, Moser C, Christensen LD, van Gennip M, et al. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax. 2010; 65(1): 57-62.
Qadri SM, Donkor DA, Bhakta V, Eltringham‐Smith LJ, Dwivedi DJ, Moore JC, Pepler et al. Phosphatidylserine externalization and procoagulant activation of erythrocytes induced by Pseudomonas
aeruginosa virulence factor pyocyanin. J Cell Mol Med. 2016; 20(4): 710-20.
Wu L, Estrada O, Zaborina O, Bains M, Shen L, Kohler JE, et al. Recognition of host immune activation by Pseudomonas aeruginosa. Science. 2005; 309(5735): 774-7.
Jensen PØ, Givskov M, Bjarnsholt T, Moser C. The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol Med Microbiol. 2010; 59(3): 292-305.
Pier GB. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol. 2007; 297(5): 277-95.
McEwan DL, Kirienko NV, Ausubel FM. Host translational inhibition by Pseudomonas aeruginosa Exotoxin A triggers an immune response in Caenorhabditis elegans. Cell Host & Microbe. 2012; 11(4): 364-74.
Pellegrino D, Bonab AA, Dragotakes SC, Pitman JT, Mariani G, Carter EA. Inflammation and infection: imaging properties of 18F-FDG–labeled white blood cells versus 18F-FDG. J Nuc Med. 2005; 46(9): 1522-30.
Razook BRF. Immunization effect of Proteus vulgaris fimbrial and lipopolysaccharide antigens in histopathological changes in some internal organs. Baghdad Sci J. 2014; 11(3): 1448-1454.
Razook BRF, Al-Samarrrae IAA, Al-Rubaie HMA. The effect of Proteus vulgaris sonicate fimbriae antigens in some blood parameters and humoral immune response. Baghdad Sci J. 2015; 12(2): 301-306.
Razook BRF. Histopathology in rabbits injected sonicated Klebsiella and Eimeria antigens challenged with virulent Klebsiella pneumonia. Online J Vet Res. 2018; 22(10): 888-900.